Cited by 590SARS-CoV-2 and COVID-19 ResearchRNA Research and Splicinginterferon and immune responses

The DOI matches its Crossref record; 96 of the 100 references it cites were found in a registry or an index.

SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses

Open access

Banerjee, Abhik K., Blanco, Mario R., Bruce, Emily A., Honson, Drew D., Chen, Linlin M., Chow, Amy, Bhat, Prashant, Ollikainen, Noah, Quinodoz, Sofia A., Loney, Colin, Thai, Jasmine, Miller, Zachary D., Lin, Aaron E., Schmidt, Madaline M., Stewart, Douglas G., Goldfarb, Daniel, De Lorenzo, Giuditta, Rihn, Suzannah J., Voorhees, Rebecca M., Botten, Jason W., Majumdar, Devdoot, Guttman, Mitchell·2020·Cell

DOI 10.1016/j.cell.2020.10.004PMC PMC7543886

Open this paper in CoChat — free account Open PDF

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently identified coronavirus that causes the respiratory disease known as coronavirus disease 2019 (COVID-19). Despite the urgent need, we still do not fully understand the molecular basis of SARS-CoV-2 pathogenesis. Here, we comprehensively define the interactions between SARS-CoV-2 proteins and human RNAs. NSP16 binds to the mRNA recognition domains of the U1 and U2 splicing RNAs and acts to suppress global mRNA splicing upon SARS-CoV-2 infection. NSP1 binds to 18S ribosomal RNA in the mRNA entry channel of the ribosome and leads to global inhibition of mRNA translation upon infection. Finally, NSP8 and NSP9 bind to the 7SL RNA in the signal recognition particle and interfere with protein trafficking to the cell membrane upon infection. Disruption of each of these essential cellular functions acts to suppress the interferon response to viral infection. Our results uncover a multipronged strategy utilized by SARS-CoV-2 to antagonize essential cellular processes to suppress host defenses.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2020.10.004

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
The Protein Data Bank
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Integrative genomics viewer
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Self-citation
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
Comparative Protein Structure Modeling Using Modeller
Eswar, N., Webb, B., Martı́-Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M., Pieper, U., & Šali, A. (2006) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi0506s15 · Cited by 4,618

Flagged first, then by citations

Show all 100 references

4 of the 100 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 590

All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses
Setaro, A. C., & Gaglia, M. M. (2021) · Current Research in Virological Science · doi:10.1016/j.crviro.2021.100015 · Cited by 42
Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?
Zheng, Z., Peng, F., & Zhou, Y. (2023) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2022.12.002 · Cited by 45
Alternative Splicing of Pre-mRNA in the Control of Immune Activity
Su, Z., & Huang, D. (2021) · Genes · doi:10.3390/genes12040574 · Cited by 44
Molecular Virology of SARS-CoV-2 and Related Coronaviruses
Kung, Y.-A., Lee, K.-M., Chiang, H.-J., Huang, S., Wu, C.-J., & Shih, S. (2022) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00026-21 · Cited by 50
COVID‐19 metabolism: Mechanisms and therapeutic targets
Wang, T., Cao, Y., Zhang, H., Wang, Z., Man, C. H., Yang, Y., Chen, L., Xu, S., Yan, X., Zheng, Q., et al. (2022) · MedComm · doi:10.1002/mco2.157 · Cited by 42
Self-citation
Immunology of COVID ‐19
Brüssow, H. (2020) · Environmental Microbiology · doi:10.1111/1462-2920.15302 · Cited by 54
Universal features of Nsp1-mediated translational shutdown by coronaviruses
Schubert, K., Karousis, E. D., Ban, I., Lapointe, C. P., Leibundgut, M., Bäumlin, E., Kummerant, E., Scaiola, A., Schönhut, T., Ziegelmüller, J., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.09.002 · Cited by 41
Optimization and Deoptimization of Codons in SARS‐CoV‐2 and Related Implications for Vaccine Development
Wu, X., Shan, K.-J., Zan, F., Tang, X., Qian, Z., & Lü, J. (2023) · Advanced Science · doi:10.1002/advs.202205445 · Cited by 38
Nsp2 has the potential to be a drug target revealed by global identification of SARS-CoV-2 Nsp2-interacting proteins
Zheng, Y.-X., Wang, L., Kong, W.-S., Chen, H., Wang, X., Meng, Q., Zhang, H., Guo, S., Jiang, H., & Tao, S. (2021) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmab088 · Cited by 39
SARS‐CoV‐2 infection remodels the host protein thermal stability landscape
Selkrig, J., Stanifer, M. L., Mateus, A., Mitosch, K., Barrio‐Hernandez, I., Rettel, M., Kim, H., Voogdt, C. G. P., Walch, P., Kee, C., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202010188 · Cited by 38
Evaluating the Virology and Evolution of Seasonal Human Coronaviruses Associated with the Common Cold in the COVID-19 Era
Harrison, C. M., Doster, J. M., Landwehr, E. H., Kumar, N. P., White, E. J., Beachboard, D. C., & Stobart, C. C. (2023) · Microorganisms · doi:10.3390/microorganisms11020445 · Cited by 41
New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic
Carvajal, J. J., García-Castillo, V., Cuellar, S. V., Campillay-Véliz, C. P., Salazar‐Ardiles, C., Avellaneda, A. M., Muñoz, C. A., Retamal-Díaz, A. R., Bueno, S. M., González, P. A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1363572 · Cited by 42
Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19
Malireddi, R. K. S., Sharma, B. R., & Kanneganti, T. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-083122-043545 · Cited by 39
Abnormal global alternative RNA splicing in COVID-19 patients
Wang, C., Chen, L., Chen, Y., Jia, W., Cai, X., Liu, Y., Ji, F., Peng, X., Liang, A., Liu, R., et al. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010137 · Cited by 39
Self-citation
The Translational Landscape of SARS-CoV-2-infected Cells Reveals Suppression of Innate Immune Genes
Puray‐Chavez, M., Lee, N., Tenneti, K., Wang, Y., Vuong, H. R., Liu, Y., Horani, A., Huang, T., Gunsten, S. P., Case, J. B., et al. (2022) · mBio · doi:10.1128/mbio.00815-22 · Cited by 49
SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis
Zhu, J., Wang, G., Huang, X., Lee, H., Lee, J., Yang, P., van de Leemput, J., Huang, W., Kane, M. A., Yang, P., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03986-6 · Cited by 37
The space between notes: emerging roles for translationally silent ribosomes
Smith, P. R., Pandit, S. C., Loerch, S., & Campbell, Z. T. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.02.003 · Cited by 35
Protease inhibitors targeting the main protease and papain-like protease of coronaviruses
Capasso, C., Nocentini, A., & Supuran, C. T. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1857726 · Cited by 40
SARS-CoV-2 dependence on host pathways
Wong, J. P., & Damania, B. (2021) · Science · doi:10.1126/science.abg6837 · Cited by 36
Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19
van de Leemput, J., & Han, Z. (2021) · Molecular and Cellular Biology · doi:10.1128/mcb.00185-21 · Cited by 37
COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19
Sapir, T., Averch, Z., Lerman, B., Bodzin, A., Fishman, Y., & Maitra, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158606 · Cited by 34
Selenoprotein S: A versatile disordered protein
Ghelichkhani, F., Gonzalez, F. A., Kapitonova, M. A., Schaefer‐Ramadan, S., Liu, J., Cheng, R., & Rozovsky, S. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109427 · Cited by 36
Molecular mechanisms of Na,K-ATPase dysregulation driving alveolar epithelial barrier failure in severe COVID-19
Kryvenko, V., & Vadász, I. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00056.2021 · Cited by 34
Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual
Yan, B., Chakravorty, S., Mirabelli, C., Wang, L., Trujillo-Ochoa, J. L., Chauss, D., Kumar, D., Lionakis, M. S., Olson, M. R., Wobus, C. E., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00294-21 · Cited by 35
NSP9 of SARS-CoV-2 attenuates nuclear transport by hampering nucleoporin 62 dynamics and functions in host cells
Makiyama, K., Hazawa, M., Kobayashi, A., Lim, K., Voon, D., & Wong, R. (2021) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2021.11.046 · Cited by 31
Highly resolved spatial transcriptomics for detection of rare events in cellsPreprint
Groiss, S., Pabst, D., Faber, C., Meier, A., Bogdoll, A., Unger, C., Nilges, B. S., Strauß, S., Föderl-Höbenreich, E., Hardt, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.11.463936 · Cited by 35
RNA regulatory mechanisms that control antiviral innate immunity
Gokhale, N. S., Smith, J. R., Gelder, R. D. V., & Savan, R. (2021) · Immunological Reviews · doi:10.1111/imr.13019 · Cited by 34
The Role of Viral RNA Degrading Factors in Shutoff of Host Gene Expression
Gaucherand, L., & Gaglia, M. M. (2022) · Annual Review of Virology · doi:10.1146/annurev-virology-100120-012345 · Cited by 32
Cytokines and microRNAs in SARS-CoV-2: What do we know?
Rarani, F. Z., Rashidi, B., Abadi, M. H. J. N., Hamblin, M. R., Hashemian, S. M. R., & Mirzaei, H. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.06.017 · Cited by 35
SARS-CoV-2 NSP1 induces mRNA cleavages on the ribosome
Tardivat, Y., Sosnowski, P., Tidu, A., Westhof, É., Eriani, G., & Martin, F. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad627 · Cited by 34
SARS-CoV-2 RNA stabilizes host mRNAs to elicit immunopathogenesis
Zhao, H., Cai, Z., Rao, J. Y., Wu, D., Ji, L., Ye, R., Wang, D., Chen, J., Cao, C., Hu, N., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.11.032 · Cited by 38
Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells
Pickard, A., Calverley, B. C., Chang, J., Garva, R., Gago, S., Lu, Y., & Kadler, K. E. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009840 · Cited by 35
An overview of viral mutagenesis and the impact on pathogenesis of SARS-CoV-2 variants
Khan, M. Z. I., Nazli, A., Al-furas, H., Asad, M. I., Ajmal, I., Khan, D., Shah, J., Farooq, M. A., & Jiang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1034444 · Cited by 37
An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models
Leekha, A., Saeedi, A., Kumar, M., Sefat, K. M. S. R., Martinez-Paniagua, M. A., Meng, H., Fathi, M., Kulkarni, R. S., Reichel, K., Biswas, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50234-y · Cited by 33
SPIDR enables multiplexed mapping of RNA-protein interactions and uncovers a mechanism for selective translational suppression upon cell stress
Wolin, E., Guo, J. K., Blanco, M. R., Goronzy, I. N., Gorhe, D., Dong, W., Perez, A. A., Keskin, A., Valenzuela, E., Abdou, A. A., et al. (2025) · Cell · doi:10.1016/j.cell.2025.06.042 · Cited by 35
Self-citation
Human Pluripotent Stem Cell Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response
Mithal, A., Hume, A. J., Lindstrom-Vautrin, J., Villacorta-Martín, C., Olejnik, J., Bullitt, E., Hinds, A., Mühlberger, E., & Mostoslavsky, G. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.02.019 · Cited by 36
Human Nasal Epithelial Cells Sustain Persistent SARS-CoV-2 Infection In Vitro , despite Eliciting a Prolonged Antiviral Response
Gamage, A. M., Tan, K. S., Chan, W. O. Y., Lew, Z. Z. R., Liu, J., Tan, C. W., Rajagopalan, D., Lin, Q. X. X., Tan, L. M., Venkatesh, P. N., et al. (2022) · mBio · doi:10.1128/mbio.03436-21 · Cited by 34
Human coronaviruses disassemble processing bodies
Kleer, M., Mulloy, R. P., Robinson, C.-A., Evseev, D., Bui-Marinos, M. P., Castle, E. L., Banerjee, A., Mubareka, S., Mossman, K. L., & Corcoran, J. A. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010724 · Cited by 36
Self-citation
Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells
Barbagallo, D., Palermo, C. I., Barbagallo, C., Battaglia, R., Caponnetto, A., Spina, V., Ragusa, M., Pietro, C. D., Scalia, G., & Purrello, M. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04119-8 · Cited by 31
The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response
Enguita, F. J., Leitão, A. L., McDonald, J. T., Zaksas, V., Das, S., Galeano, D., Taylor, D. M., Wurtele, E. S., Saravia-Butler, A., Baylin, S. B., et al. (2022) · Theranostics · doi:10.7150/thno.73268 · Cited by 31
SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids
Stewart, R., Yan, K., Ellis, S. A., Bishop, C. R., Dumenil, T. D., Tang, B., Nguyen, W., Larcher, T., Parry, R. H., Sng, J. D. J., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1320856 · Cited by 34
Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19
Tan, Y., Zhang, W., Zhu, Z., Qiao, N., Ling, Y., Guo, M., Tong, Y., Fang, H., Xu, X., Lü, G., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00274-1 · Cited by 29
MVIP: multi-omics portal of viral infection
Tang, Z., Fan, W., Li, Q., Wang, D., Wen, M., Wang, J., Li, X., & Zhou, Y. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab958 · Cited by 29
A diminished immune response underlies age-related SARS-CoV-2 pathologies
Oishi, K., Horiuchi, S., Frere, J. J., Schwartz, R. E., & tenOever, B. R. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111002 · Cited by 30
Characterisation of the blood RNA host response underpinning severity in COVID-19 patients
Jackson, H., Calle, I. R., Broderick, C. M., Habgood-Coote, D., D’Souza, G., Nichols, S., Vito, O., Rial, J. G., Rivero-Velasco, C., Rodríguez‐Núñez, N., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15547-2 · Cited by 33
Structural insights into the activity regulation of full-length non-structural protein 1 from SARS-CoV-2
Wang, Y., Kirkpatrick, J., Lage, S. Z., & Carlomagno, T. (2023) · Structure · doi:10.1016/j.str.2022.12.006 · Cited by 30
The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2 and Necroptosis, Pyroptosis, and PANoptosis
Schifanella, L., Anderson, J. L., Wieking, G., Southern, P. J., Antinori, S., Galli, M., Corbellino, M., Lai, A., Klatt, N. R., Schacker, T. W., et al. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad056 · Cited by 30
SARS-CoV-2 NSP1 C-terminal (residues 131–180) is an intrinsically disordered region in isolation
Kumar, A., Kumar, A., Kumar, P., Garg, N., & Giri, R. (2021) · Current Research in Virological Science · doi:10.1016/j.crviro.2021.100007 · Cited by 29
COVID-19: A Mitochondrial Perspective
Prasun, P. (2021) · DNA and Cell Biology · doi:10.1089/dna.2020.6453 · Cited by 29
Studying SARS-CoV-2 with Fluorescence Microscopy
Putlyaeva, L. V., & Lukyanov, K. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126558 · Cited by 27
Platelet proteome reveals features of cell death, antiviral response and viral replication in covid-19
Trugilho, M. R. O., de Azevedo-Quintanilha, I. G., Gesto, J. S. M., Moraes, E. C. D. S., Mandacaru, S. C., Campos, M. M., Oliveira, D. M., Dias, S. D. S. G., Bastos, V. A., Santos, M. D. M., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01122-1 · Cited by 29
Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection
Islamuddin, M., Mustfa, S. A., Ullah, S. N. M. N., Omer, U., Kato, K., & Parveen, S. (2022) · Inflammation · doi:10.1007/s10753-022-01651-y · Cited by 31
Exploring the expanding universe of host-virus interactions mediated by viral RNA
Castelló, A., Álvarez, L., Kamel, W., Iselin, L., & Hennig, J. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.08.027 · Cited by 27
Epitranscriptomics of SARS-CoV-2 Infection
Izadpanah, A., Rappaport, J., & Datta, P. K. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.849298 · Cited by 28
Predicted coronavirus Nsp5 protease cleavage sites in the human proteome
Scott, B. M., Lacasse, V., Blom, D. G., Tonner, P. D., & Blom, N. (2022) · BMC Genomic Data · doi:10.1186/s12863-022-01044-y · Cited by 27
The SARS-CoV-2 protein NSP2 impairs the silencing capacity of the human 4EHP-GIGYF2 complex
Zou, L., Moch, C., Graille, M., & Chapat, C. (2022) · iScience · doi:10.1016/j.isci.2022.104646 · Cited by 30
Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern
Murer, L., Volle, R., Andriasyan, V., Petkidis, A., Gómez-González, A., Yang, L., Meili, N., Suomalainen, M., Bauer, M., Sequeira, D. P., et al. (2022) · Current Research in Virological Science · doi:10.1016/j.crviro.2022.100019 · Cited by 25
Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
Rovito, R., Augello, M., Ben-Haim, A., Bono, V., Monforte, A. D., & Marchetti, G. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.912336 · Cited by 27
Principles and correction of 5’-splice site selection
Malard, F., Mackereth, C. D., & Campagne, S. (2022) · RNA Biology · doi:10.1080/15476286.2022.2100971 · Cited by 28
SARS-CoV-2 and the host-immune response
Maison, D. P., Deng, Y., & Gerschenson, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1195871 · Cited by 29
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
Naidu, A. S., Wang, C., Rao, P., Mancini, F., Clemens, R., Wirakartakusumah, A., Chiu, H., Yen, C., Porretta, S., Mathai, I., et al. (2024) · npj Science of Food · doi:10.1038/s41538-024-00261-2 · Cited by 32
In vitro reconstitution of SARS-CoV-2 Nsp1-induced mRNA cleavage reveals the key roles of the N-terminal domain of Nsp1 and the RRM domain of eIF3gPreprint
Abaeva, I. S., Arhab, Y., Miścicka, A., Hellen, C. U. T., & Pestova, T. V. (2023) · Genes & Development · doi:10.1101/gad.350829.123 · Cited by 28
Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors
Quarleri, J. F., & Delpino, M. V. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.01.003 · Cited by 27
Attenuating innate immunity and facilitating β-coronavirus infection by NSP1 of SARS-CoV-2 through specific redistributing hnRNP A2/B1 cellular localization
Zhou, F., Wan, Q., Chen, S., Chen, Y., Wang, P.-H., Yao, X., & He, M. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00786-y · Cited by 26
Serum Protein Profiling Reveals a Specific Upregulation of the Immunomodulatory Protein Progranulin in Coronavirus Disease 2019
Rieder, M., Wirth, L., Pollmeier, L., Jeserich, M., Goller, I., Baldus, N., Schmid, B., Busch, H.-J., Hofmann, M., Thimme, R., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa741 · Cited by 25
Proteoform medicine: characterizing and targeting protein forms in human disease
Korchak, J. A., Yi, S. S., Kelleher, N. L., Sahni, N., & Sheynkman, G. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-025-00915-1 · Cited by 26
CovInter: interaction data between coronavirus RNAs and host proteins
Amahong, K., Zhang, W., Zhou, Y., Zhang, S., Yin, J., Li, F., Xu, H., Yan, T., Yue, Z., Liu, Y., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac834 · Cited by 24
Identification of the susceptibility genes for COVID-19 in lung adenocarcinoma with global data and biological computation methods
Gao, L., Li, G., Li, J., He, J., Zhang, Y., Zhou, H., Kong, J., & Chen, G. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.11.026 · Cited by 25
Viral and cellular translation during SARS‐CoV‐2 infection
Eriani, G., & Martin, F. (2022) · FEBS Open Bio · doi:10.1002/2211-5463.13413 · Cited by 23
The immune response as a double‐edged sword: The lesson learnt during the COVID ‐19 pandemic
Agrati, C., Carsetti, R., Bordoni, V., Sacchi, A., Quintarelli, C., Locatelli, F., Ippolito, G., & Capobianchi, M. R. (2022) · Immunology · doi:10.1111/imm.13564 · Cited by 22
RNA-Binding Proteins at the Host-Pathogen Interface Targeting Viral Regulatory Elements
Embarc-Buh, A., Francisco-Velilla, R., & Martínez-Salas, E. (2021) · Viruses · doi:10.3390/v13060952 · Cited by 20
SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways
Oh, S. J., & Shin, O. S. (2022) · The Journal of Microbiology · doi:10.1007/s12275-022-1525-1 · Cited by 23
Translational Control of COVID-19 and Its Therapeutic Implication
Zhang, D., Zhu, L., Wang, Y., Li, P., & Gao, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.857490 · Cited by 25
Translation of SARS-CoV-2 gRNA Is Extremely Efficient and Competitive despite a High Degree of Secondary Structures and the Presence of an uORF
Condé, L., Allatif, O., Ohlmann, T., & de Breyne, S. (2022) · Viruses · doi:10.3390/v14071505 · Cited by 26
EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus replication through the E3 ubiquitin ligase MARCH8
Zhao, Y.-H., Sui, L.-Y., Wu, P., Li, L.-T., Liu, L., Ma, B.-H., Wang, W.-F., Chi, H., Wang, Z.-D., Wei, Z., et al. (2023) · Journal of Virology · doi:10.1128/jvi.01028-23 · Cited by 22
Nsp1 of SARS-CoV-2 stimulates host translation termination
Shuvalov, A. V., Shuvalova, E., Biziaev, N., Sokolova, E., Evmenov, K., Pustogarov, N., Arnautova, A., Matrosova, V. A., Egorova, T., & Alkalaeva, E. Z. (2021) · RNA Biology · doi:10.1080/15476286.2021.1999103 · Cited by 22
Coronaviral Infection and Interferon Response: The Virus-Host Arms Race and COVID-19
Liu, Q., Chi, S., Dmytruk, K. V., Dmytruk, O. V., & Tan, S. (2022) · Viruses · doi:10.3390/v14071349 · Cited by 24
Nsp14 of SARS-CoV-2 inhibits mRNA processing and nuclear export by targeting the nuclear cap-binding complex
Katahira, J., Ohmae, T., Yasugi, M., Sasaki, R., Itoh, Y., Kohda, T., Hieda, M., Hirai, M. Y., Okamoto, T., & Miyamoto, Y. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad483 · Cited by 22
Identification of Amino Acids within Nonstructural Proteins 10 and 14 of the Avian Coronavirus Infectious Bronchitis Virus That Result in Attenuation In Vivo and In Ovo
Keep, S., Stevenson-Leggett, P., Dowgier, G., Everest, H., Freimanis, G. L., Oade, M. S., Hammond, J., Armesto, M., Vila, R., Bru, T., et al. (2022) · Journal of Virology · doi:10.1128/jvi.02059-21 · Cited by 22
What do we know about the function of SARS-CoV-2 proteins?
Arévalo, S. J., Chávez, A. C., Calampa, C. S. U., Sifuentes, D. Z., Huallpa, C. J., Bianchi, G. L., Casas, R. G.-S., Aguilar, M. Q., & Pineda, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1249607 · Cited by 23
Systems Bioinformatics Reveals Possible Relationship between COVID-19 and the Development of Neurological Diseases and Neuropsychiatric Disorders
Onisiforou, A., & Spyrou, G. M. (2022) · Viruses · doi:10.3390/v14102270 · Cited by 19
RNA virus infections and their effect on host alternative splicing
Sehrawat, S., & García-Blanco, M. A. (2022) · Antiviral Research · doi:10.1016/j.antiviral.2022.105503 · Cited by 22
CRL4B E3 ligase recruited by PRPF19 inhibits SARS-CoV-2 infection by targeting ORF6 for ubiquitin-dependent degradation
Zhang, L., Hao, P., Chen, X., Lv, S., Gao, W., Li, C., Li, Z., & Zhang, W. (2024) · mBio · doi:10.1128/mbio.03071-23 · Cited by 21
Betacoronavirus-specific alternate splicing
Karlebach, G., Aronow, B. J., Baylin, S. B., Butler, D., Foox, J., Levy, S. A., Meydan, C., Mozsary, C., Saravia-Butler, A., Taylor, D. M., et al. (2022) · Genomics · doi:10.1016/j.ygeno.2022.110270 · Cited by 20
Antiviral responses versus virus-induced cellular shutoff: a game of thrones between influenza A virus NS1 and SARS-CoV-2 Nsp1
Khalil, A. M., Nogales, A., Martínez‐Sobrido, L., & Mostafa, A. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1357866 · Cited by 19
Insights into coronavirus immunity taught by the murine coronavirus
Grabherr, S., Ludewig, B., & Pikor, N. B. (2021) · European Journal of Immunology · doi:10.1002/eji.202048984 · Cited by 20
Transcriptome-wide changes in gene expression, splicing, and lncRNAs in response to a live attenuated dengue virus vaccine
Kim, E., Che, Y., Dean, H. J., Lorenzo-Redondo, R., Stewart, M. G., Keller, C., Whorf, D., Mills, D. E., Dulin, N. N., Kim, T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110341 · Cited by 18
An Emerging Role for Type I Interferons as Critical Regulators of Blood Coagulation
Ryan, T. A. J., & O'Neill, L. A. J. (2023) · Cells · doi:10.3390/cells12050778 · Cited by 19
SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?
Sacchi, A., Giannessi, F., Sabatini, A., Percario, Z. A., & Affabris, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119353 · Cited by 21
Virus usurps alternative splicing to clear the decks for infection
Li, R., Gao, S., Chen, H., Zhang, X., Yang, X., Zhao, J., & Wang, Z. (2023) · Virology Journal · doi:10.1186/s12985-023-02098-9 · Cited by 18
SARS CoV-2 Nucleoprotein Enhances the Infectivity of Lentiviral Spike Particles
Mishra, T. K., Sreepadmanabh, M., Ramdas, P., Sahu, A. K., Kumar, A., & Chande, A. G. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.663688 · Cited by 18
Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin
Mattoo, S.-U.-S., Kim, S., Ahn, D., & Myoung, J. (2022) · Viruses · doi:10.3390/v14030530 · Cited by 18
Identification of serum metabolites enhancing inflammatory responses in COVID-19
Zhang, C., Zhang, B., Li, M., Wei, X., Gong, K., Li, Z., Yao, X., Wu, J., Zhang, C., Zhu, M., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2099-7 · Cited by 15
The nervous system during COVID ‐19: Caught in the crossfire
Natale, N. R., Lukens, J. R., & Petri, W. A. (2022) · Immunological Reviews · doi:10.1111/imr.13114 · Cited by 19
Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19
Loh, D., & Reiter, R. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158122 · Cited by 17
Alternative Polyadenylation Is a Novel Strategy for the Regulation of Gene Expression in Response to Stresses in Plants
Wu, J., Ma, L., & Cao, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054727 · Cited by 18
A viral pan-end RNA element and host complex define a SARS-CoV-2 regulon
Khan, D., Terenzi, F., Liu, G., Ghosh, P. K., Ye, F., Nguyen, K., China, A., Ramachandiran, I., Chakraborty, S., Stefan, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39091-3 · Cited by 18
Genome-wide CRISPR screens identify noncanonical translation factor eIF2A as an enhancer of SARS-CoV-2 programmed −1 ribosomal frameshifting
Wei, L.-H., Sun, Y., & Guo, J. U. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112987 · Cited by 17
An Evolutionarily Conserved Strategy for Ribosome Binding and Host Translation Inhibition by β-coronavirus Non-structural Protein 1
Maurina, S. F., O'Sullivan, J. P., Sharma, G., Rodríguez, D., MacFadden, A., Cendali, F. I., Henen, M. A., Vögeli, B., Kieft, J. S., Glasgow, A. A., et al. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168259 · Cited by 17
Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses
Hartmann, J., Cardoso, M., Talarico, M. C. R., Kenney, D., Leone, M. R., Reese, D. C., Turcinovic, J., O'Connell, A., Gertje, H., Marino, C., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.026 · Cited by 16

Authors: Banerjee, A. K., Blanco, M. R., Bruce, E. A., Honson, D. D., Chen, L. M., Chow, A., Bhat, P., Ollikainen, N., Quinodoz, S. A., Loney, C., Thai, J., Miller, Z. D., Lin, A. E., Schmidt, M. M., Stewart, D. G., Goldfarb, D., De Lorenzo, G., Rihn, S. J., Voorhees, R. M., Botten, J. W., Majumdar, D., & Guttman, M.
Affiliations: University of Southern California (US)
California Institute of Technology (US)
University of Vermont (US)
MRC University of Glasgow Centre for Virus Research (GB)
Broad Institute (US)
Corresponding author: Majumdar, Devdoot
Guttman, Mitchell
ORCID: Banerjee, Abhik K.
Blanco, Mario R.
Bruce, Emily A.
Honson, Drew D.
Chen, Linlin M.
Chow, Amy
Bhat, Prashant
Ollikainen, Noah
Quinodoz, Sofia A.
Loney, Colin
Miller, Zachary D.
Lin, Aaron E.
Schmidt, Madaline M.
Stewart, Douglas G.
Goldfarb, Daniel
De Lorenzo, Giuditta
Rihn, Suzannah J.
Voorhees, Rebecca M.
Botten, Jason W.
Majumdar, Devdoot
Guttman, Mitchell
Venue: Cell
Publisher: Elsevier BV
Published: 2020-11
Volume: 183
Issue: 5
Pages: 1325-1339.e21
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2020.10.004
PMC: PMC7543886
OpenAlex: W3092296275
Cited by: 583
References: 100
Citations by year: 2026: 40 · 2025: 64 · 2024: 80 · 2023: 106 · 2022: 149 · 2021: 129 · 2020: 15
FWCI: 13.29
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by/4.0/ (vor)
Locations: Cell (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
CaltechAUTHORS (California Institute of Technology) (submittedVersion, cc-by)
Funders: Wellcome Trust
University of Vermont
Heritage Medical Research Institute
American Cancer Society
Foundation for the National Institutes of Health
Chan Zuckerberg Initiative
California Institute of Technology
New York Stem Cell Foundation
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Keywords: SARS-CoV-2, COVID-19 pandemic, host-virus interaction, nsp16, Nsp1, 18S rRNA, mRNA translation inhibition, nsp8, nsp9, 7SL RNA, signal recognition particle, protein trafficking, viral pathogenesis
MeSH terms: A549 Cells, COVID-19, SARS-CoV-2, Animals, Chlorocebus aethiops, Humans, Interferons, RNA Splicing, RNA, Messenger, RNA, Ribosomal, 18S, Protein Biosynthesis, Vero Cells, Viral Nonstructural Proteins, Signal Recognition Particle, RNA, Small Cytoplasmic, Protein Transport, Host-Pathogen Interactions, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks